These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 1379121

  • 1. Correlation between in vivo toxicity and preclinical in vitro parameters for the immunotoxin anti-B4-blocked ricin.
    Grossbard ML, Lambert JM, Goldmacher VS, Blättler WA, Nadler LM.
    Cancer Res; 1992 Aug 01; 52(15):4200-7. PubMed ID: 1379121
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Serotherapy of B-cell neoplasms with anti-B4-blocked ricin: a phase I trial of daily bolus infusion.
    Grossbard ML, Freedman AS, Ritz J, Coral F, Goldmacher VS, Eliseo L, Spector N, Dear K, Lambert JM, Blättler WA.
    Blood; 1992 Feb 01; 79(3):576-85. PubMed ID: 1370636
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Lineage specific treatment of adult patients with acute lymphoblastic leukemia in first remission with anti-B4-blocked ricin or high-dose cytarabine: Cancer and Leukemia Group B Study 9311.
    Szatrowski TP, Dodge RK, Reynolds C, Westbrook CA, Frankel SR, Sklar J, Stewart CC, Hurd DD, Kolitz JE, Velez-Garcia E, Stone RM, Bloomfield CD, Schiffer CA, Larson RA.
    Cancer; 2003 Mar 15; 97(6):1471-80. PubMed ID: 12627512
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Adjuvant immunotoxin therapy with anti-B4-blocked ricin after autologous bone marrow transplantation for patients with B-cell non-Hodgkin's lymphoma.
    Grossbard ML, Gribben JG, Freedman AS, Lambert JM, Kinsella J, Rabinowe SN, Eliseo L, Taylor JA, Blättler WA, Epstein CL.
    Blood; 1993 May 01; 81(9):2263-71. PubMed ID: 8481509
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cytotoxicity against human tumor cells mediated by the conjugate of anti-epidermal growth factor receptor monoclonal antibody to recombinant ricin A chain.
    Masui H, Kamrath H, Apell G, Houston LL, Mendelsohn J.
    Cancer Res; 1989 Jul 01; 49(13):3482-8. PubMed ID: 2786451
    [Abstract] [Full Text] [Related]

  • 16. Anti-CD6-blocked ricin: an anti-pan T-cell immunotoxin.
    Collinson AR, Lambert JM, Liu Y, O'Dea C, Shah SA, Rasmussen RA, Goldmacher VS.
    Int J Immunopharmacol; 1994 Jan 01; 16(1):37-49. PubMed ID: 8150554
    [Abstract] [Full Text] [Related]

  • 17. Antitumor activity of L6-ricin immunotoxin against the H2981-T3 lung adenocarcinoma cell line in vitro and in vivo.
    Schmidberger H, King L, Lasky LC, Vallera DA.
    Cancer Res; 1990 Jun 01; 50(11):3249-56. PubMed ID: 1692258
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.
    Bregni M, De Fabritiis P, Raso V, Greenberger J, Lipton J, Nadler L, Rothstein L, Ritz J, Bast RC.
    Cancer Res; 1986 Mar 01; 46(3):1208-13. PubMed ID: 3510720
    [Abstract] [Full Text] [Related]

  • 20. In vitro and in vivo antitumor activity of ZENECA ZD0490, a recombinant ricin A-chain immunotoxin for the treatment of colorectal cancer.
    Calvete JA, Newell DR, Wright AF, Rose MS.
    Cancer Res; 1994 Sep 01; 54(17):4684-90. PubMed ID: 8062265
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.